Open Access

De-escalation of monotherapy with P2Y12 inhibitor. An alternative approach.

Seminar Presentation

About the speaker

Doctor Jose Luis Ferreiro

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)
2 presentations
0 follower

4 more presentations in this session

Welcome & Introduction .

Speaker: Doctor G. Vilahur (Barcelona, ES)


Dual anti platelet therapy duration? Very short or very long?

Speaker: Professor J. ten Berg (Nieuwegein, NL)


Very low dose of rivaroxaban. It is time for a new era.

Speaker: Professor J. Morais (Leiria, PT)


The bleeding risk the true game changer.

Speaker: Professor T. Geisler (Tuebingen, DE)


Access the full session

Welcome and Session 1: From ACS to chronic coronary artery disease. The transition period

Speakers: Doctor J. Ferreiro, Doctor G. Vilahur, Professor J. ten Berg, Professor J. Morais, Professor T. Geisler

About the event


Hot topics and new insights for Thrombosis 2022

17 March 2022 17:00 CET

Related content

ACVC Premium Access

The patient with acute myocarditis.

19 March 2022

Open Access

First-line cryoablation for Atrial Fibrillation: Turning evidence into practice.

27 August 2021

ESC Premium Access

Masters Athlete Screening Study (MASS): incidence of cardiovascular disease and major adverse cardiac events over five years of screening

27 August 2021

ESC 365 is supported by

logo Novo Nordisk